Form 4: STERIS plc: Executive Stock Transaction Details
Statement of Changes in Beneficial Ownership
Mary Clare Fraser of STERIS plc reported a transaction involving the withholding of 600 ordinary shares for tax purposes upon the vesting of restricted shares.
Summary
- Mary Clare Fraser, SVP & Chief HR Officer of STERIS plc, reported a transaction on June 4, 2026.
- 600 ordinary shares were withheld from a total of 1,360 restricted shares that vested on that date.
- These withheld shares were used to cover applicable employment or tax liabilities, valued at the NYSE closing market price on June 4, 2026.
- Following this transaction, Ms. Fraser beneficially owns 13,716 ordinary shares.
- As of June 8, 2026, 5,359 of these ordinary shares remain restricted, with restrictions lapsing on various dates between June 2, 2027, and June 4, 2029.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider stock transaction and tax withholding, with no significant positive or negative implications for the company's financial health or strategic direction.
Positives
- Vesting of restricted shares indicates continued employee incentive and retention programs.
- The withholding of shares for tax purposes is a standard and expected practice, demonstrating compliance.
- Ms. Fraser continues to hold a significant number of shares (13,716) after the transaction.
Negatives
- A portion of vested shares (600) were immediately disposed of to cover taxes, reducing the immediate net gain for the executive.
Future Outlook
The filing details the scheduled lapse of restrictions on 5,359 ordinary shares over the next several years, indicating a phased release of equity incentives.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for publicly traded companies, detailing changes in beneficial ownership by insiders. This specific filing reflects standard executive compensation practices involving restricted stock units and tax withholding.
Stakeholder Impact
- Shareholders: No immediate impact, as this is a standard insider transaction. The ongoing vesting schedule may influence future share availability.
- Employees: The vesting and tax withholding process is a standard component of executive and employee compensation.
- Management: Reflects the ongoing compensation structure for key executives.
Next Steps
- Lapse of restrictions on remaining restricted shares according to the schedule provided.
Key Dates
| Date | Description |
|---|---|
| 06/04/2026 | Date of transaction (vesting of restricted shares and tax withholding). |
| 06/08/2026 | Date as of which beneficial ownership and remaining restricted shares are reported. |
| 06/02/2027 | Date for lapse of restriction on 1,003 ordinary shares. |
| 06/03/2027 | Date for lapse of restriction on 835 ordinary shares. |
| 06/04/2027 | Date for lapse of restriction on 680 ordinary shares. |
| 06/02/2028 | Date for lapse of restriction on 1,003 ordinary shares. |
| 06/05/2028 | Date for lapse of restriction on 835 ordinary shares. |
| 06/04/2029 | Date for lapse of restriction on 1,003 ordinary shares. |
Keywords
STERIS plc, STE, Form 4, Stock Transaction, Beneficial Ownership, Restricted Shares, Vesting, Tax Withholding, Executive Compensation, Mary Clare Fraser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.